Predicting Relapse with Circulating Tumor DNA Analysis in Lung Cancer.
View/ Open
Date
2017-12ICR Author
Author
Comino-Mendez, I
Turner, N
Type
Journal Article
Metadata
Show full item recordAbstract
Advances in circulating tumor DNA (ctDNA) analysis are revealing new treatment strategies for patients with cancer. Detection of residual disease with ctDNA analysis predicts relapse with high accuracy after treatment for early-stage lung cancer. Cancer Discov; 7(12); 1368-70. ©2017 AACRSee related article by Chaudhuri et al., p. 1394.
Collections
Subject
Humans
Lung Neoplasms
Neoplasm Recurrence, Local
Circulating Tumor DNA
Research team
Molecular Oncology
Language
eng
Date accepted
2017-10-11
License start date
2017-12
Citation
Cancer discovery, 2017, 7 (12), pp. 1368 - 1370